NFE2L2 and neoplasm: The standardised tumour mutation burden (TMB) analysis is shown in Figure 3A, where NFE2L2, NOTCH1, SYNE2, FAT3, PAPPA2 and FMN2 showed lower mutation frequencies in the low‐risk corner.